Synthetic Biology: Recent Trends & Research

Best in Biotech 13 Mar 2025

Nine biotechs thriving in Seattle in 2025

In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.

March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter

Reports

Produced by Inpart

7 Feb 2025

Partnering 2030: FME Industries Report

Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.

February 7, 2025

Produced by Inpart

Best in Biotech 14 Jan 2025

Singapore’s biotech scene: 7 companies leading the way in 2025

Discover seven of the top biotech companies in Singapore – a country that set out to become a global biotech hub just over 20 years ago.

January 14, 2025 - 11 minutesmins - By Willow Shah-Neville

Podcast 5 Apr 2024

Colossal Biosciences’ 2028 goal: Bringing back the woolly mammoth

Discover the pioneering work of Colossal Biosciences, a biotech firm leading the charge in de-extinction and endangered species preservation.

April 5, 2024

In Depth 7 Jul 2023

The future of food: what’s behind the cell-cultured meat industry regulations?

The first-ever lab-grown burger was created at Maastricht University in the Netherlands, and eaten at a news conference in London in 2013. While everyone who tried a bite had something different to say about the taste and texture of the meat, it was agreed that this could be the start of something big. The technology […]

July 7, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 4 Jul 2023

Camena Bioscience raises $10M for DNA synthesis platform

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its DNA synthesis platform, gSynth. Camena Bioscience is the first company to offer the enzyme-based DNA synthesis […]

July 4, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 10 May 2023

Scientists create first CRISPR-based drug candidate targeting the microbiome

A new CRISPR-based drug candidate targeting E. coli in the gut microbiome is in phase 1 clinical trials. According to a new paper published in Nature Biotechnology, it may improve the well-being of blood cancer patients and reduce their mortality rate from E. coli infections. Many people have experienced infections from E. coli, which are […]

May 10, 2023 - 6 minutesmins - By Jim Cornall

Best in Biotech 28 Apr 2023

Six synthetic biology companies that have made a mark

The consequences of the climate crisis coupled with soil degradation and its impact on food and water security, seem dire. But, as ambitious as it may sound, synthetic biology companies could alleviate some of the environmental burden that the planet faces. As it involves the redesigning of organisms by genetically engineering them to have new, […]

April 28, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 7 Feb 2023

Evonetix closes $24M financing

Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a $24 million financing round, extending its total series B funding to over $54 million. This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round. The […]

February 7, 2023 - 2 minutesmins - By Jim Cornall

In Depth 6 Feb 2023

The biggest private biotech investments in January 2023

The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted the biggest funding rounds. 2023 began with a bang in terms of biotech funding, and there are signs of stabilization in biotech stocks after two […]

February 6, 2023 - 4 minutesmins - By Jonathan Smith

In Depth 20 Jan 2023

The future of single-cell microfluidics in cell engineering

By Richard Hammond, chief technical officer at Sphere Fluidics Single-cell microfluidic-based techniques continue to be a key enabling technology for cell engineering as they allow true single-cell level working, with the associated precision of measurement and control of environment, and a high level of automation, enabling the speed and scale necessary to process and search […]

January 20, 2023 - 3 minutesmins - By External Contributor

News and Trends 20 Dec 2022

Ribbon Biolabs milestone to lead to 2023 market entry

DNA synthesis company Ribbon Biolabs has announced the successful implementation of its InfiniSynth platform for the automated assembly of sequence-agnostic and long DNA. The company achieved the milestone in collaboration with HighRes Biosolutions, a laboratory automation technology company. The InfiniSynth platform enables Ribbon Biolabs to enter the market in 2023 with a highly differentiated approach […]

December 20, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Synthetic biology

Nine biotechs thriving in Seattle in 2025

Partnering 2030: FME Industries Report

Singapore’s biotech scene: 7 companies leading the way in 2025

Colossal Biosciences’ 2028 goal: Bringing back the woolly mammoth

The future of food: what’s behind the cell-cultured meat industry regulations?

Camena Bioscience raises $10M for DNA synthesis platform

Scientists create first CRISPR-based drug candidate targeting the microbiome

Six synthetic biology companies that have made a mark

Evonetix closes $24M financing

The biggest private biotech investments in January 2023

The future of single-cell microfluidics in cell engineering

Ribbon Biolabs milestone to lead to 2023 market entry

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!